Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO
RM Lombel, DS Gipson, EM Hodson - Pediatric nephrology, 2013 - Springer
Abstract The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice
guideline on glomerulonephritis (GN) is intended to assist the practitioner caring for patients …
guideline on glomerulonephritis (GN) is intended to assist the practitioner caring for patients …
Pharmacokinetic boosting of calcineurin inhibitors in transplantation: Pros, cons, and perspectives
S Pattanaik, C Monchaud - Therapeutic Drug Monitoring, 2025 - journals.lww.com
The concept of pharmacokinetic (PK) boosting of calcineurin inhibitors (CNI) emerged after
the FDA approval of cyclosporine-A. Several studies followed, and the proof of concept was …
the FDA approval of cyclosporine-A. Several studies followed, and the proof of concept was …
Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological …
TN Johnson, A Rostami‐Hodjegan - Pediatric Anesthesia, 2011 - Wiley Online Library
Summary Aims and Objectives:(i) To describe an example of the development work required
for building a 'pediatric physiologically based pharmacokinetic'(P‐PBPK) model (Simcyp …
for building a 'pediatric physiologically based pharmacokinetic'(P‐PBPK) model (Simcyp …
Childhood Nephrotic Syndrome in Africa: Epidemiology, Treatment Trends, and Outcomes
Nephrotic syndrome is a common childhood glomerular disease that is associated with
massive proteinuria and edema. Children with nephrotic syndrome are at risk of chronic …
massive proteinuria and edema. Children with nephrotic syndrome are at risk of chronic …
Management of focal segmental glomerulosclerosis in resource-limited regions
S Banerjee, M Bonilla-Felix - Pediatric Nephrology, 2024 - Springer
The management of focal segmental glomerulosclerosis (FSGS) is challenging, and a
definitive long-term cure remains elusive. It is associated with poor outcomes due to …
definitive long-term cure remains elusive. It is associated with poor outcomes due to …
[PDF][PDF] 环孢素与其他药物相互作用的临床研究
刘治军， 傅得兴， 孙春华， 张亚同 - 药物不良反应杂志, 2006 - cadrj.com
药物不良反应杂志2006 年6 月第8 卷第3 期ADRJ, June 2006, Vol. 8, No. 3 d 后CsA
的血药浓度降至95 Ug/L, CsA 用量又调整到200 mg. 2 次/d 后, 其血药浓度重新升到300 Ug/L …
的血药浓度降至95 Ug/L, CsA 用量又调整到200 mg. 2 次/d 后, 其血药浓度重新升到300 Ug/L …
[PDF][PDF] SINGLE-CENTER EXPERIENCE WITH CYCLOSPORINE FOR TREATMENT OF IDIOPATHIC MINIMAL CHANGE NEPHROTIC SYN-DROME IN CHILDREN
Introduction: Cyclosporine A is used in the treatment of idiopathic nephrotic syndrome. We
conducted this study to evaluate the effect of cyclosporine and its combination with …
conducted this study to evaluate the effect of cyclosporine and its combination with …
[PDF][PDF] Update on the treatment of glomerulonephritis in adults in low-to-middle-income countries
IG Okpechi, OI Ameh - NEPHROLOGY, 2018 - pdfs.semanticscholar.org
BACKGROUND Glomerular diseases are a significant cause of chronic kidney disease
(CKD) in many low-tomiddle-income countries (LMIC), and CKD has been associated with a …
(CKD) in many low-tomiddle-income countries (LMIC), and CKD has been associated with a …
Antifungal drugs
D Schrey, TJ Walsh, AH Groll - Side Effects of Drugs Annual, 2010 - Elsevier
Publisher Summary This chapter describes the adverse effects of antifungal drugs, such as
terbinafine (allylamines), amphotericin, azoles, and echinocandins. Terbinafine can cause a …
terbinafine (allylamines), amphotericin, azoles, and echinocandins. Terbinafine can cause a …
Клинические практические рекомендации KDIGO по лечению гломерулонефритов
К Даниел, Ф Джон, К Теренс, Ф Фернандо… - Нефрология и …, 2014 - journal.nephro.ru
Аннотация Kidney International supplements Volume 2/issue 2/June 2012 http://www.
kidney-international. org Перевод ЛС Бирюковой, ЕВ Захаровой и ЕВ Кальяновой под …
kidney-international. org Перевод ЛС Бирюковой, ЕВ Захаровой и ЕВ Кальяновой под …